{
  "id": "2708738cf6389093",
  "title": "FDA Awards National Priority Voucher to Teclistamab Plus Daratumumab in Relapsed / Refractory Multiple Myeloma",
  "description": "20251216T190000Z",
  "content": "",
  "source": "pharmacytimes.com",
  "source_url": "https://www.pharmacytimes.com/view/fda-awards-national-priority-voucher-to-teclistamab-plus-daratumumab-in-relapsed-refractory-multiple-myeloma",
  "published_at": "20251216T190000Z",
  "fetched_at": "2025-12-17T00:22:43.797460+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.pharmacytimes.com/view/fda-awards-national-priority-voucher-to-teclistamab-plus-daratumumab-in-relapsed-refractory-multiple-myeloma",
    "url_mobile": "",
    "title": "FDA Awards National Priority Voucher to Teclistamab Plus Daratumumab in Relapsed / Refractory Multiple Myeloma",
    "seendate": "20251216T190000Z",
    "socialimage": "https://cdn.sanity.io/images/0vv8moc6/pharmacytimes/1759f627343ce3ca54c39401af6cff42ea3b2849-6500x4333.jpg",
    "domain": "pharmacytimes.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}